Drugs affecting the respiratory system

Slides:



Advertisements
Similar presentations
Respiratory Medicines
Advertisements

Bronchodilators and Other Respiratory Agents
PHRM-511 L.S.No-6 v-1 Drugs Affecting the Respiratory System
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 36 Antihistamines, Decongestants, Antitussives,
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 77 Drugs for Allergic Rhinitis, Cough, and Colds.
CHAPTER 37 Bronchodilators and Other Respiratory Drugs
Treatment of cough By : Dr. Mahmoud A. Naga.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 36 Bronchodilators and Other Respiratory Agents.
Copyright © 2015 Cengage Learning® Chapter 26 Respiratory System Drugs and Antihistamines.
Chapter 15 Expectorants and Antitussive Agents. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 15 -
Drugs Affecting the Respiratory System
Mosby items and derived items © 2005, 2002 by Mosby, Inc.
Antihistamines, Decongestants, Antitussives, and Expectorants
Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. The Pharmacy Technician: Foundations and Practices.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 37 CHAPTER 37 Bronchodilators and Other Respiratory.
Drugs to Treat Respiratory Disorders. Bronchoconstriction Result from release ACH, histamine and inflammatory mediators Vagus nerve releases ACH ACH triggers.
Drugs For Treating Asthma
RESPIRATORY SYSTEM PHARMACOLOGY
Chapter 14 Antihistamines and Nasal Decongestants.
Antihistamines and Nasal Decongestants.  Allergic Rhinitis  Environmental allergens -> inflammation  Sinusitis  Middle ear infections  Upper Respiratory.
Diseases and Abnormal Conditions of The Respiratory System
Drugs Affecting the Respiratory System
Drugs for Treating Colds & Allergies Chapter 10. Understanding the Common Cold  Most caused by viral infection (rhinovirus or influenza virus—the “flu”)
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Respiratory Medications
Bronchodilating Drugs Pat Woodbery, ARNP, CS Professor of Nursing.
AFAMS Respiratory System Drugs (Insert Dari) EO Part 30.
Drugs Used to Treat Lower Respiratory Disease
Bronchodilators Lilley Pharmacology Text: Chapter 35
PTP 546 Module 7 Respiratory Pharmacology
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 36 Bronchodilators and Other Respiratory Drugs.
Antihistamines, Decongestants, Antitussives, and Expectorants Lilley Pharmacology Text: Chapter 34 Original Text modified by: Anita A. Kovalsky, R.N.,
Chapter 9 Respiratory System Drugs Copyright © 2011 Delmar, Cengage Learning.
RESPIRATORY DRUGS CHAPTER 6. ANTITUSSIVES -The cough reflex occurs when receptors in the airway send impulses to the brainstem and cause contraction of.
Pharmacology II – Respiratory and Oxygenation Kathy Plitnick RN PhD CCRN Georgia Baptist College of Nursing of Mercer University.
Bronchodilators and Other Respiratory Agents. Asthma -Predominantly in boys 2:1 -puberty: occurrence equals out -More females in adult-onset cases -Affects.
Drugs Affecting Respiratory System. Antihistamines Drugs that directly compete with histamine for specific receptor sites Two histamine receptors –H 1.
Plants Used for Respiratory Problems - I. Respiratory Problems Various conditions can interfere with the gas exchange in the lungs Infectious disease.
Focus on PHARMACOLOGY ESSENTIALS FOR HEALTH PROFESSIONALS CHAPTER Drugs Used to Treat Respiratory Conditions 28.
Antihistamines and Nasal Decongestants
Bronchodilators and Other Respiratory Agents
Drugs Used to Treat Asthma Dr. Najlaa Saadi Ismael Department of Pharmacology Mosul college of Medicine University of Mosul.
Drugs Affecting the Respiratory System
Allergic Rhinitis- inflammation of the nasal airways from an allergen (dust, pollen, animal dander). Symptoms runny noseitching eye rednessswelling Treatment-
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 40 DRUGS FOR UPPER RESPIRATORY DISORDERS.
Drugs for Upper Respiratory Disorders
Drugs affecting the respiratory system
Bronchodilators and Other Respiratory Agents. Drugs Affecting the Respiratory System  Bronchodilators  Xanthine derivatives  Beta-agonists  Anticholinergics.
Department of Pharmacology
Drugs for Allergic Rhinitis, Cough, and Colds. Allergic Rhinitis  Inflammatory disorder of the upper airway, lower airway, and eyes  Symptoms  Sneezing.
Respiratory Medications. Antihistamines Histamine is released in response to injury and produces inflammation. Antihistamines counteract this by competing.
Bronchodilators and Other Respiratory Agents
Drugs for Allergic Rhinitis, Cough, and Colds
Medications That Affect the Respiratory System
Drugs for Upper Respiratory Disorders
28 Drugs Used to Treat Respiratory Conditions.
Antihistamines, antitussives, decongestants, expectorants
Focus on Pharmacology Essentials for Health Professionals
Chapter 9 Respiratory Drugs.
Drugs affecting the respiratory system
Drugs Used to Treat Lower Respiratory Disease
UNIT 8: DRUGS USED IN THE TREATMENT OF RESPIRATORY DISORDERS
RESPIRATORY PHARMACOLOGY
DRUGS AFFECTING THE RESPIRATORY SYSTEM
Antihistamines and Nasal Decongestants
Nonsteroidal antiasthma agents
Drugs Affecting the Respiratory System
Drugs Affecting the Respiratory System
Pharmacology II – Respiratory and Oxygenation
Presentation transcript:

Drugs affecting the respiratory system Antihistamines, Decongestants, Antitussives & Expectorants Dr.Amira Yahia

Understanding the Common Cold Most caused by viral infection (rhinovirus or influenza virus—the “flu”) Virus invades tissues (mucosa) of upper respiratory tract, causing upper respiratory infection (URI)

Antihistamines Drugs that directly compete with histamine for specific receptor sites Two histamine receptors H1 (histamine1) H2 (histamine2)

Antihistamines (cont’d) H1 histamine receptor- found on smooth muscle, endothelium, and central nervous system tissue; causes vasodilation, bronchoconstriction, smooth muscle activation, and separation of endothelia cellss (responsible for hives), and pain and itching due to insect stings H1 antagonists are commonly referred to as antihistamines Antihistamines have several properties Antihistaminic Anticholinergic Sedative

Antihistamines (cont’d) H2 blockers or H2 antagonists Used to reduce gastric acid Examples: cimetidine, ranitidine, famotidine

Antihistamines: Mechanism of Action Block action of histamine at the H1 receptor sites Compete with histamine for binding at unoccupied receptors Cannot push histamine off the receptor if already bound

Antihistamines: Mechanism of Action (cont’d) The binding of H1 blockers to the histamine receptors prevents the adverse consequences of histamine stimulation Vasodilation Increased GI and respiratory secretions Increased capillary permeability

Antihistamines: Indications Management of: Nasal allergies Seasonal or perennial allergic rhinitis (hay fever) Allergic reactions Motion sickness Sleep disorders

Antihistamines: Indications (cont’d) Also used to relieve symptoms associated with the common cold Sneezing, runny nose Palliative treatment, not curative

Antihistamines: Side effects Anticholinergic (drying) effects, most common Dry mouth Difficulty urinating Constipation Changes in vision Drowsiness Mild drowsiness to deep sleep

Antihistamines: Nursing Implications Gather data about the condition or allergic reaction that required treatment; also assess for drug allergies Contraindicated in the presence of acute asthma attacks and lower respiratory diseases Use with caution in increased intraocular pressure, cardiac or renal disease, hypertension, asthma, COPD, peptic ulcer disease, BPH, or pregnancy

Antihistamines: Nursing Implications (cont’d) Instruct clients to report excessive sedation, confusion, or hypotension Avoid driving or operating heavy machinery, and do not consume alcohol or other CNS depressants Do not take these medications with other prescribed or OTC medications without checking with prescriber

Antihistamines: Nursing Implications (cont’d) Best tolerated when taken with meals—reduces GI upset If dry mouth occurs, teach client to perform frequent mouth care, chew gum, or suck on hard candy to ease discomfort Monitor for intended therapeutic effects

Decongestants

Nasal Congestion Excessive nasal secretions Inflamed and swollen nasal mucosa Primary causes Allergies Upper respiratory infections (common cold)

Decongestants: Types (cont’d) Two dosage forms Oral Inhaled/topically applied to the nasal membranes

Oral Decongestants Prolonged decongestant effects, but delayed onset Effect less potent than topical No rebound congestion Exclusively adrenergics Example: pseudoephedrine, Sinutab, Dristan, Tylenol cold, Sudafed

Topical Nasal Decongestants Topical adrenergics Prompt onset Potent Sustained use over several days causes rebound congestion, making the condition worse Eg: DRISTAN* DECONGESTANT NASAL MIST (SOLUTION) COMPOSITION: Each 1 mL of solution contains:         Phenylephrine HCl        5 mg         Pheniramine Maleate        2 mg

Topical Nasal Decongestants (cont’d) Adrenergics desoxyephedrine phenylephrine Intranasal steroids beclomethasone dipropionate flunisolide fluticasone

Nasal Decongestants: Mechanism of Action Site of action: blood vessels surrounding nasal sinuses Adrenergics Constrict small blood vessels that supply URI structures As a result these tissues shrink, and nasal secretions in the swollen mucous membranes are better able to drain Nasal stuffiness is relieved

Nasal Decongestants: Mechanism of Action (cont’d) Site of action: blood vessels surrounding nasal sinuses Nasal steroids Anti-inflammatory effect Work to turn off the immune system cells involved in the inflammatory response Decreased inflammation results in decreased congestion Nasal stuffiness is relieved

Nasal Decongestants: Indications Relief of nasal congestion associated with: Acute or chronic rhinitis Common cold Sinusitis Hay fever Other allergies

Nasal Decongestants: Indications (cont’d) May also be used to reduce swelling of the nasal passage and facilitate visualization of the nasal/pharyngeal membranes before surgery or diagnostic procedures

Nasal Decongestants: Side Effects Adrenergics Steroids Nervousness Local mucosal dryness Insomnia and irritation Palpitations Tremors (systemic effects due to adrenergic stimulation of the heart, blood vessels, and CNS)

Nasal Decongestants: Nursing Implications Decongestants may cause hypertension, palpitations, and CNS stimulation—avoid in clients with these conditions Clients on medication therapy for hypertension should check with their physician before taking OTC decongestants Assess for drug allergies

Nasal Decongestants: Nursing Implications (cont’d) Clients should avoid caffeine and caffeine-containing products Report a fever, cough, or other symptoms lasting longer than a week Monitor for intended therapeutic effects

Antitussives

Antitussives: Definition Drugs used to stop or reduce coughing Opioid and nonopioid (narcotic and nonnarcotic) Used only for nonproductive coughs!

Antitussives: Mechanism of Action Opioids Suppress the cough reflex by direct action on the cough centre in the medulla Examples: codeine hydrocodone

Antitussives: Mechanism of Action (cont’d) Nonopioids Suppress the cough reflex by numbing the stretch receptors in the respiratory tract and preventing the cough reflex from being stimulated Examples: Dextromethorphan, Nyquil, Robitussin

Antitussives: Indications Used to stop the cough reflex when the cough is nonproductive and/or harmful

Antitussives: Side Effects Dextromethorphan Dizziness, drowsiness, nausea Opioids Sedation, nausea, vomiting, lightheadedness, constipation

Antitussive Agents: Nursing Implications Perform respiratory and cough assessment, and assess for allergies Instruct clients to avoid driving or operating heavy equipment due to possible sedation, drowsiness, or dizziness If taking chewable tablets or lozenges, do not drink liquids for 30 to 35 minutes afterward

Antitussive Agents: Nursing Implications (cont’d) Report any of the following symptoms to the caregiver Cough that lasts more than a week A persistent headache Fever Rash Antitussive agents are for nonproductive coughs Monitor for intended therapeutic effects

Expectorants

Expectorants: Definition Drugs that aid in the expectoration (removal) of mucus Reduce the viscosity of secretions Disintegrate and thin secretions

Expectorants: Mechanisms of Action Direct stimulation Reflex stimulation Final result: thinner mucus that is easier to remove

Expectorants: Mechanism of Action (cont’d) Reflex stimulation Agent causes irritation of the GI tract Loosening and thinning of respiratory tract secretions occur in response to this irritation Example: guaifenesin Direct stimulation The secretory glands are stimulated directly to increase their production of respiratory tract fluids Examples: iodine-containing products such as iodinated glycerol and potassium iodide

Expectorants: Drug Effects By loosening and thinning sputum and bronchial secretions, the tendency to cough is indirectly diminished

Expectorants: Indications Used for the relief of nonproductive coughs associated with: Common cold Bronchitis Laryngitis Pharyngitis Coughs caused by chronic paranasal sinusitis Pertussis Influenza Measles

Expectorants: Nursing Implications Expectorants should be used with caution in the elderly or those with asthma or respiratory insufficiency Clients taking expectorants should receive more fluids, if permitted, to help loosen and liquefy secretions Report a fever, cough, or other symptoms lasting longer than a week Monitor for intended therapeutic effects

Bronchodilators and Other Respiratory Agents

Table 36-2 Stepwise approach to the management of asthma

Table 36-3 Mechanisms of anti-asthmatic drug action

Diseases of the Lower Respiratory Tract Bronchial asthma Emphysema Chronic bronchitis COPD Cystic fibrosis Acute respiratory distress syndrome

Agents Used to Treat Asthma Long-term control Antileukotrienes Cromoglycate Inhaled steroids Long-acting beta2-agonists Quick relief Intravenous systemic corticosteroids Short-acting inhaled beta2-agonists ipratropium nedocromil theophylline

Bronchodilators and Respiratory Agents Xanthine derivatives Beta-adrenergic agonists Anticholinergics Antileukotrienes Corticosteroids Mast cell stabilizers

Bronchodilators: Xanthine Derivatives Plant alkaloids: caffeine, theobromine, and theophylline Only theophylline is used as a bronchodilator Examples: aminophylline Theophylline Slo-Bid® Uniphyl®

Xanthine Derivatives: Drug Effects Cause bronchodilation by relaxing smooth muscles of the airways Result: relief of bronchospasm and greater airflow into and out of the lungs Also cause CNS stimulation Slow onset action and are mostly used for prevention Aminophylline(Status asthmaticus)

Xanthine Derivatives: Drug Effects (cont’d) Also cause cardiovascular stimulation: increased force of contraction and increased HR, resulting in increased cardiac output and increased blood flow to the kidneys (diuretic effect)

Xanthine Derivatives: Indications Dilation of airways in asthmas, chronic bronchitis, and emphysema Mild to moderate cases of acute asthma Adjunct agent in the management of COPD

Xanthine Derivatives: Side Effects Nausea, vomiting, anorexia Gastroesophageal reflux during sleep Sinus tachycardia, extrasystole, palpitations, ventricular dysrhythmias Transient increased urination

Nursing Implications: Xanthine Derivatives Contraindications: history of PUD or GI disorders Cautious use: cardiac disease

Bronchodilators: Beta-Agonists Large group, sympathomimetics Used during acute phase of asthmatic attacks Quickly reduce airway constriction and restore normal airflow Stimulate beta2-adrenergic receptors throughout the lungs

Bronchodilators: Beta-Agonists (cont’d) Three types Nonselective adrenergics Stimulate alpha-, beta1- (cardiac), and beta2- (respiratory) receptors Example: epinephrine Nonselective beta-adrenergics Stimulate both beta1- and beta2-receptors Example: isoproterenol Selective beta2 drugs Stimulate only beta2-receptors Example: salbutamol

Beta-Agonists: Indications Relief of bronchospasm related to asthma, bronchitis, and other pulmonary diseases Useful in treatment of acute attacks as well as prevention

Beta-Agonists: Side Effects Beta2 (salbutamol) Hypotension OR hypertension Vascular headaches Tremor Contraindicated: clients with allergies, tachyarythmias, severe cardiac disease

Nursing Implications Encourage clients to take measures that promote a generally good state of health in order to prevent, relieve, or decrease symptoms of COPD Avoid exposure to conditions that precipitate bronchospasms (allergens, smoking, stress, air pollutants) Adequate fluid intake Compliance with medical treatment Avoid excessive fatigue, heat, extremes in temperature, caffeine

Nursing Implications (cont’d) Perform a thorough assessment before beginning therapy, including: Skin colour Baseline vital signs Respirations (should be <12 or >24 breaths/min) Respiratory assessment, including SaO2 Sputum production Allergies History of respiratory problems Other medications

Nursing Implications (cont’d) Teach clients to take bronchodilators exactly as prescribed Ensure that clients know how to use inhalers and MDIs, and have the clients demonstrate use of devices Monitor for side effects

Nursing Implications (cont’d) Monitor for therapeutic effects Decreased dyspnea Decreased wheezing, restlessness, and anxiety Improved respiratory patterns with return to normal rate and quality Improved activity tolerance Decreased symptoms and increased ease of breathing

Anticholinergics: Mechanism of Action Acetylcholine (ACh) causes bronchial constriction and narrowing of the airways Anticholinergics bind to the ACh receptors, preventing ACh from binding Result: bronchoconstriction is prevented, airways dilate

Anticholinergics Atrovent (ipratropium bromide) is the only anticholinergic used for respiratory disease Slow and prolonged action Used to prevent bronchoconstriction NOT used for acute asthma exacerbations! Combivent (salbutamol/ipratroprium)

Anticholinergics (cont’d) Side effects: Dry mouth or throat Gastrointestinal distress Headache Coughing Anxiety No known drug interactions

Antileukotrienes Also called leukotriene receptor antagonists (LRTAs) Newer class of asthma medications Three subcategories of agents

Antileukotrienes (cont’d) Currently available agents: Montelukast (sold as Singulair®) Zafirlukast (sold as Accolate®)

Antileukotrienes: Mechanism of Action Leukotrienes are substances released when a trigger, such as cat hair or dust, starts a series of chemical reactions in the body Leukotrienes cause inflammation, bronchoconstriction, and mucus production Result: coughing, wheezing, shortness of breath

Antileukotrienes: Mechanism of Action (cont’d) Antileukotriene agents prevent leukotrienes from attaching to receptors on cells in the lungs and in circulation Inflammation in the lungs is blocked, and asthma symptoms are relieved

Antileukotrienes: Drug Effects By blocking leukotrienes: Prevent smooth muscle contraction of the bronchial airways Decrease mucus secretion Prevent vascular permeability Decrease neutrophil and leukocyte infiltration to the lungs, preventing inflammation

Antileukotrienes: Indications Prophylaxis and chronic treatment of asthma in adults and children older than age 12 NOT meant for management of acute asthmatic attacks Montelukast is approved for use in children ages 6 and older

Antileukotrienes: Side Effects zafirlukast Headache Nausea Diarrhea Liver dysfunction montelukast has fewer side effects

Antileukotrienes: Nursing Implications Ensure that the drug is being used for chronic management of asthma, not acute asthma Teach the client the purpose of the therapy Improvement should be seen in about 1 week

Corticosteroids Anti-inflammatory Used for chronic asthma Do not relieve symptoms of acute asthmatic attacks Oral or inhaled forms Inhaled forms reduce systemic effects May take several weeks before full effects are seen

Corticosteroids: Mechanism of Action Stabilize membranes of cells that release harmful bronchoconstricting substances These cells are leukocytes, or white blood cells Also increase responsiveness of bronchial smooth muscle to beta-adrenergic stimulation

Inhaled Corticosteroids Budesonide (Pulmicort®) Fluticasone (Flovent®)

Inhaled Corticosteroids: Indications Treatment of bronchospastic disorders that are not controlled by conventional bronchodilators NOT considered first-line agents for management of acute asthmatic attacks or status asthmaticus

Inhaled Corticosteroids: Side Effects Pharyngeal irritation Coughing Dry mouth Oral fungal infections Systemic effects are rare because of the low doses used for inhalation therapy

Inhaled Corticosteroids: Nursing Implications Contraindicated in client with psychosis, fungal infections, AIDS, TB Cautious use in clients with diabetes, glaucoma, osteoporosis, PUD, renal disease, HF, edema Teach clients to gargle and rinse the mouth with water afterward to prevent the development of oral fungal infections

Inhaled Corticosteroids: Nursing Implications (cont’d) Abruptly discontinuing these medications can lead to serious problems If discontinuing, should be weaned for 1 to 2 weeks, only if recommended by physician Report any weight gain of more than 2.5 kg a week or the occurrence of chest pain

PO corticosteroids Prednisolone (sold as Pediapred®) Prednisone (sold as Deltasone®)

Combination medications Corticosteroids Budesonide (Pumicort®) Formoterol (Oxeze®) Long-Acting bronchodilator Fluticasone (Flovent®) Salmeterol (Severent®)

Mast Cell Stabilizers Cromoglycate (sold as Intal®) Nedocromil (sold as Tilade®) Ketotifen fumarate (sold as Zaditen®)

Mast Cell Stabilizers: Indications Adjuncts to the overall management of asthma Used solely for prophylaxis, NOT for acute asthma attacks Used to prevent exercise-induced bronchospasm Used to prevent bronchospasm associated with exposure to known precipitating factors, such as cold, dry air or allergens

Mast Cell Stabilizers: Side Effects Coughing Sore throat Rhinitis Bronchospasm Taste changes Dizziness Headache

Mast Cell Stabilizers: Nursing Implications For prophylactic use only Contraindicated for acute exacerbations Not recommended for children younger than age 5 Therapeutic effects may not be seen for up to 4 weeks Teach clients to gargle and rinse the mouth with water afterward to minimize irritation to the throat and oral mucosa

Inhalers: Client Education For any inhaler prescribed, ensure that the client is able to self-administer the medication Provide demonstration and return demonstration Ensure the client knows the correct time intervals for inhalers Provide a spacer if the client has difficulty coordinating breathing with inhaler activation